Steven Robert Martin - Feb 4, 2022 Form 4 Insider Report for Ensysce Biosciences, Inc. (ENSC)

Role
Director
Signature
/s/ Steve R. Martin
Stock symbol
ENSC
Transactions as of
Feb 4, 2022
Transactions value $
$0
Form type
4
Date filed
2/4/2022, 02:22 PM
Previous filing
Jul 2, 2021
Next filing
Jun 27, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ENSC Stock Option Award +20K 20K Feb 4, 2022 Common Stock 20K $3.13 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On February 4, 2022, Mr. Martin was granted an option (the "Stock Option") to purchase 20,000 shares of common stock of Ensysce Biosciences, Inc. (the "Company"), par value $0.01 per share, with an exercise price of $3.13, under the that certain Ensysce Biosciences, Inc. Amended and Restated 2021 Omnibus Incentive Plan. The Stock Option is scheduled to vest on the date of the Company's annual stockholder meeting in 2022.